FibroGen (FGEN) Tops Q3 EPS by 21c

November 8, 2016 4:05 PM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.38), $0.21 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $24.3 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings